Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
However, based on the pricing of comparable medications (Wegovy at ~$1,350/month and Zepbound at ~$1,060/month), analysts anticipate retatrutide will be priced similarly, potentially between $1,000 and $1,500 per month at list price
(12) These challenges lengthen hospital stays, increase the need for readmissions or revision procedures, and impair long-term functional outcomes
True success in weight management is measured in stability and wellbeing, not speed
SeCys is transported to the cytoplasm and is reacted with glutamic acid to form -glutamyl-Se-methylselenocysteine (GMSC) by -glutamyl-cysteine synthetase (Figure 2, step 8)